DDDD - ETF AI Analysis
Top Page
YieldMax U.S. Stocks Target Double Distribution ETF (DDDD)
Rating:74Outperform
Price Target:―
Positive Factors
Broad Sector Mix
The ETF spreads its investments across many sectors, which helps reduce the impact if any single industry runs into trouble.
Strong Energy and Health Care Exposure
Several top holdings in energy and health care have shown strong recent performance, providing support for the fund’s returns.
Positive Recent Performance
The ETF has delivered steady gains over the past month and year-to-date, indicating that its strategy has been working in the current market.
Negative Factors
High Expense Ratio
The fund’s expense ratio is relatively high, which means more of the returns are eaten up by fees compared with many other ETFs.
U.S.-Only Geographic Focus
Almost all of the ETF’s assets are invested in U.S. companies, offering little diversification across international markets.
Mixed Performance Among Top Holdings
Some major positions, such as Abbott Laboratories and Home Depot, have shown weaker recent performance, which can drag on overall fund results.
DDDD vs. SPDR S&P 500 ETF (SPY)
AUM6.56M
RegionNorth America
Expense Ratio1.01%
Beta0.03
IssuerYieldMax
Inception DateMar 11, 2026
Dividend Yield1.54%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume11,335
30 Day Avg. Volume6,258
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
35.93Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering100
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DDDD Summary
YieldMax U.S. Stocks Target Double Distribution ETF (DDDD) is an income-focused fund that aims to pay higher cash distributions by investing in a broad mix of strong U.S. dividend-paying companies through the Schwab U.S. Dividend Equity ETF (SCHD) and then using options to boost income. Its holdings include well-known names like Abbott Laboratories and Procter & Gamble, giving investors exposure to health care, consumer goods, energy, and more. Someone might consider this ETF if they want diversified U.S. stock exposure with a focus on higher income. A key risk is that the fund’s price and payouts can go up and down, and the options strategy may limit gains in strong markets.
How much will it cost me?This ETF has an expense ratio of 1.01%, which means you’ll pay about $10.10 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed and uses a more complex options strategy to try to boost income.
What would affect this ETF?This ETF could benefit if the U.S. economy stays stable, interest rates fall, and large, established dividend payers in sectors like health care, consumer staples, and energy remain profitable, since that supports both dividend payments and the options income strategy. On the downside, a sharp market rally could see the fund lag because its options approach can cap gains, while rising rates, tighter regulations, or sector-specific problems for key holdings like Texas Instruments, UnitedHealth, or Chevron could pressure both stock prices and the income it can generate.
DDDD Top 10 Holdings
This ETF leans heavily on steady, dividend-rich U.S. blue chips, with health care and consumer staples doing much of the heavy lifting. Merck, Amgen, and Coca-Cola have been rising nicely, giving the fund a solid backbone, while Chevron’s recent strength in energy adds extra fuel to returns. On the flip side, Home Depot and PepsiCo have been losing a bit of steam, acting as mild brakes rather than full-on drags. With all its exposure in U.S. names and an options overlay, the fund trades some upside for a smoother, income-focused ride.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 4.66% | $305.53K | $182.90B | -16.96% | 73 Outperform | |
| Amgen | 4.41% | $288.79K | $207.87B | 29.74% | 77 Outperform | |
| Merck & Company | 4.36% | $285.54K | $321.57B | 64.21% | 80 Outperform | |
| Coca-Cola | 4.32% | $283.34K | $376.86B | 27.20% | 75 Outperform | |
| UnitedHealth | 4.29% | $281.54K | $376.34B | 74.29% | 72 Outperform | |
| Home Depot | 4.09% | $268.35K | $331.00B | -11.16% | 66 Neutral | |
| Procter & Gamble | 3.95% | $258.84K | $336.46B | -4.09% | 69 Neutral | |
| Chevron | 3.90% | $255.58K | $392.01B | 30.01% | 71 Outperform | |
| Verizon | 3.80% | $249.22K | $195.46B | 9.16% | 81 Outperform | |
| PepsiCo | 3.78% | $248.01K | $190.48B | 0.20% | 78 Outperform |
DDDD Technical Analysis
Positive
―
Price Trends
32.00
Positive
Market Momentum
0.32
Negative
59.22
Neutral
55.81
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DDDD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.31, equal to the 50-day MA of 32.00, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.32 indicates Negative momentum. The RSI at 59.22 is Neutral, neither overbought nor oversold. The STOCH value of 55.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DDDD.
DDDD Peer Comparison
Comparison Results
Performance Comparison
DDDD
YieldMax U.S. Stocks Target Double Distribution ETF
32.78
2.48
8.18%
FDIV
MarketDesk Focused U.S. Dividend ETF
―
―
―
PAYR
Federated Hermes Enhanced Income ETF
―
―
―
DIVY
Sound Equity Income ETF
―
―
―
VUS
Virtus US Dividend ETF
―
―
―
JHDV
John Hancock U.S. High Dividend ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents